{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,11]],"date-time":"2026-02-11T15:59:28Z","timestamp":1770825568883,"version":"3.50.1"},"reference-count":44,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2023,10,11]],"date-time":"2023-10-11T00:00:00Z","timestamp":1696982400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Endocrinol."],"abstract":"<jats:sec><jats:title>Purpose<\/jats:title><jats:p>To investigate the prevalence of low blood testosterone level (LTL) and its determinant factors among active male acromegaly patients, as well as the effect of surgery on LTL in male acromegaly patients.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>A retrospective, single-center study focused on 252 male acromegaly patients aged 18 years\u201360 years diagnosed in the Peking Union Medical College Hospital from January 2015 to December 2018 was carried out. The measurements of preoperative and postoperative testosterone levels, serum growth hormone (GH), insulin-like growth factor 1 (IGF-1), and other clinical data were analyzed.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Forty per cent of subjects included were diagnosed with LTL pre surgery. Patients were divided into normal testosterone level (NTL) and LTL groups based on their testosterone level. There were significant differences (<jats:italic>p<\/jats:italic> &amp;lt; 0.01) between groups in the presence of macroadenomas, invasion of the cavernous sinus, compression of the optic chiasm, and serum GH and prolactin levels pre surgery. Invasion of the cavernous sinus [odds ratio (OR) = 4.299; <jats:italic>p<\/jats:italic> = 0.000] and serum prolactin level (OR = 1.023, <jats:italic>p<\/jats:italic> = 0.001) were independent predictors of LTLs in male patients before surgical intervention. A total of 67.9% of LTL patients recovered during the follow-up, with a new-onset rate of 3.4%. Body mass index, invasion of the cavernous sinus, GH, IGF-1, and prolactin levels, the presence of a prolactin-secreting tumor, and recovery from acromegaly were significantly different (<jats:italic>p<\/jats:italic> &amp;lt; 0.05) in the NTL group and in the LTL group during the follow-up. The presence of a prolactin-secreting tumor (OR = 0.224; <jats:italic>p<\/jats:italic> = 0.001) and recovery from acromegaly (OR = 0.168; <jats:italic>p<\/jats:italic> = 0.006) were independent predictors of LTLs in male acromegaly patients during the follow-up.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>The invasiveness of tumor and levels of blood prolactin are independent factors for LTLs before surgery, whereas GH and IGF-1 levels are not. Most male patients can recover from LTL after tumor restriction surgery: those who recover from acromegaly have a better chance of recovering from LTL.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fendo.2023.1259529","type":"journal-article","created":{"date-parts":[[2023,10,11]],"date-time":"2023-10-11T07:21:25Z","timestamp":1697008885000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":3,"title":["Preoperative and postoperative blood testosterone levels in patients with acromegaly: a prospective study"],"prefix":"10.3389","volume":"14","author":[{"given":"Duoxing","family":"Zhang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaopeng","family":"Guo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ming","family":"Feng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xinjie","family":"Bao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kan","family":"Deng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yong","family":"Yao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wei","family":"Lian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bing","family":"Xing","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hanbi","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2023,10,11]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1007\/s40618-018-0928-7","article-title":"Use of administrative health databases to estimate incidence and prevalence of acromegaly in Piedmont Region, Italy","volume":"42","author":"Caputo","year":"2019","journal-title":"J Endocrinol Invest"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1007\/s11154-022-09721-0","article-title":"Acromegaly and male sexual health","volume":"23","author":"Salvio","year":"2022","journal-title":"Rev Endocrine Metab Disord"},{"key":"B3","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1007\/s11102-012-0420-x","article-title":"A consensus on the diagnosis and treatment of acromegaly complications","volume":"16","author":"Melmed","year":"2013","journal-title":"Pituitary"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.12669\/pjms.37.7.4277","article-title":"Prevalence of comorbidities among patients with acromegaly","volume":"37","author":"Khan","year":"2021","journal-title":"Pak J Med Sci"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1055\/s-2002-36707","article-title":"Hypogonadotropic hypogonadism","volume":"20","author":"Silveira","year":"2002","journal-title":"Semin In Reprod Med"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1016\/j.bpobgyn.2012.05.004","article-title":"Management of anovulatory infertility,\u201d Baillieres Best Practice and Research","volume":"26","author":"Li","year":"2012","journal-title":"Clin Obstetrics Gynaecol"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(13)61126-5","article-title":"Male hypogonadism","volume":"383","author":"Basaria","year":"2014","journal-title":"Lancet"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1016\/j.beem.2010.12.002","article-title":"Diagnosis and treatment of hypogonadism in men","volume":"25","author":"Bhasin","year":"2011","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"key":"B9","doi-asserted-by":"publisher","first-page":"796","DOI":"10.3390\/brainsci12060796","article-title":"Hypogonadism in male patients with pituitary adenoma and its related mechanism: A review of literature","volume":"12","author":"Yan","year":"2022","journal-title":"Brain Sci"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.2174\/1381612823666170503150955","article-title":"Low testosterone levels and metabolic syndrome in aging male","volume":"23","author":"Blaya","year":"2017","journal-title":"Curr Pharm Design"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1007\/s40266-019-00716-2","article-title":"Is testosterone replacement therapy in older men effective and safe","author":"Yabluchanskiy","year":"2019","journal-title":"Drugs Aging"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1055\/s-0042-124355","article-title":"Hypogonadotropic hypogonadism in non-functioning pituitary adenomas: impact of intervention","volume":"125","author":"Monteiro","year":"2017","journal-title":"Exp Clin Endocrinol Diabetes"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2014-2700","article-title":"Acromegaly: an endocrine society clinical practice guideline","volume":"99","author":"Katznelson","year":"2014","journal-title":"J Clin Endocrinol Metab"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2009-2354","article-title":"\u201cTestosterone therapy in men with androgen deficiency syndromes: an Endocrine Society clinical practice guideline,\u201d","volume":"95","author":"Bhasin","year":"2010","journal-title":"J Clin Endocrinol Metab"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1227\/00006123-199310000-00008","article-title":"Pituitary adenomas with invasion of the cavernous sinus space: A magnetic resonance imaging classification compared with surgical findings","volume":"33","author":"Knosp","year":"1993","journal-title":"Neurosurgery"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2009-2670","article-title":"\u201cA consensus on criteria for cure of acromegaly,\u2019","volume":"95","author":"Giustina","year":"2010","journal-title":"J Clin Endocrinol Metab"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2021.807054","article-title":"Hyperprolactinemia and hypopituitarism in acromegaly and effect of pituitary surgery: long-term follow-up on 529 patients","volume":"12","author":"Guo","year":"2022","journal-title":"Front Endocrinol (Lausanne)"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.20945\/2359-3997000000193","article-title":"Determinants of morbidities and mortality in acromegaly","volume":"63","author":"Kasuki","year":"2019","journal-title":"Arch Endocrinol Metab"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1007\/s11154-020-09588-z","article-title":"Multidisciplinary management of acromegaly: A consensus","volume":"21","author":"Giustina","year":"2020","journal-title":"Rev Endocrine Metab Disord"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2265.2009.03667.x","article-title":"Prevalence of pituitary adenomas: a community-based, cross-sectional study in Banbury (Oxfordshire, UK)","volume":"72","author":"Fernandez","year":"2010","journal-title":"Clin Endocrinol"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2006-1668","article-title":"High prevalence of pituitary adenomas: a cross- sectional study in the province of Liege, Belgium","volume":"91","author":"Daly","year":"2006","journal-title":"J Clin Endocrinol Metab"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1530\/EJE-15-0189","article-title":"The epidemiology of pituitary adenomas in Iceland, 1955\u20132012: a nationwide population-based study","volume":"173","author":"Agustsson","year":"2015","journal-title":"Eur J Endocrinol"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2010-0537","article-title":"Incidence of pituitary adenomas in Northern Finland in 1992\u20132007","volume":"95","author":"Raappana","year":"2010","journal-title":"J Clin Endocrinol Metab"},{"key":"B24","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1530\/EJE-07-0358","article-title":"AcroBel\u2013the Belgian registry on acromegaly: a survey of the \u2018real-life\u2019 outcome in 418 acromegalic subjects","volume":"157","author":"Bex","year":"2007","journal-title":"Eur J Endocrinol"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1007\/s11102-012-0454-0","article-title":"Prevalence and incidence of pituitary adenomas: a population based study in Malta","volume":"16","author":"Gruppetta","year":"2013","journal-title":"Pituitary"},{"key":"B26","article-title":"BMI classification percentile and cut off points","volume-title":"StatPearls","author":"Weir","year":"2022"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1159\/000486001","article-title":"Metabolic complications of acromegaly","volume":"49","author":"Mercado","year":"2018","journal-title":"Front Hormone Res"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1530\/EJE-14-0144","article-title":"The incidence rate of pituitary adenomas in western Sweden for the period 2001\u20132011","volume":"171","author":"Tj\u00f6rnstrand","year":"2014","journal-title":"Eur J Endocrinol"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1007\/s00330-023-09412-7","article-title":"Shape and texture analyses based on conventional MRI for the preoperative prediction of the aggressiveness of pituitary adenomas","volume":"33","author":"Wang","year":"2023","journal-title":"Eur Radiol"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1007\/s40618-020-01296-4","article-title":"Predictive model of surgical remission in acromegaly: age, presurgical GH levels and Knosp grade as the best predictors of surgical remission","volume":"44","author":"Araujo-Castro","year":"2021","journal-title":"J Endocrinol Invest"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1016\/s1470-2045(03)01191-4","article-title":"Effects of radiation on normal tissue: consequences and mechanisms","volume":"4","author":"Stone","year":"2003","journal-title":"Lancet Oncol"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1507\/endocrj.EJ20-0596","article-title":"GH-induced LH hyporesponsiveness as a potential mechanism for hypogonadism in male patients with acromegaly","volume":"68","author":"Nishio","year":"2021","journal-title":"Endocrine J"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1055\/a-1207-1132","article-title":"Hyperprolactinemia in acromegaly is related to prolactin secretion by somatolactotroph tumours","volume":"52","author":"Van Laethem","year":"2020","journal-title":"Hormone Metab Res"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2265.2004.02002.x","article-title":"Age-related changes in testosterone and the role of replacement therapy in older men","volume":"60","author":"Allan","year":"2004","journal-title":"Clin Endocrinol"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1016\/j.mce.2009.06.007","article-title":"Obesity and testicular function","volume":"316","author":"Mah","year":"2010","journal-title":"Mol Cell Endocrinol"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1111\/j.1743-6109.2012.02735.x","article-title":"Hormonal causes of male sexual dysfunctions and their management (hyperprolactinemia, thyroid disorders, GH disorders, and DHEA)","volume":"10","author":"Maggi","year":"2013","journal-title":"J Sexual Med"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1038\/sj.ijir.3901043","article-title":"Hyperprolactinemia and sexual function in men: a short review","volume":"15","author":"Buvat","year":"2003","journal-title":"Int J Impotence Res"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.3171\/2015.1.JNS141543","article-title":"Improved versus worsened endocrine function after transsphenoidal surgery for nonfunctional pituitary adenomas: rate, time course, and radiological analysis","volume":"124","author":"Jahangiri","year":"2016","journal-title":"J Neurosurg"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1210\/jcem.82.8.4163","article-title":"Long-term effect of testosterone therapy on bone mineral density in hypogonadal men","volume":"82","author":"Behre","year":"1997","journal-title":"J Clin Endocrinol Metab"},{"key":"B40","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1210\/jendso\/bvaa090","article-title":"\u201cEffects of testosterone on serum concentrations, fat-free mass, and physical performance by population: A meta-analysis,\u201d","volume":"4","author":"Varanoske","year":"2020","journal-title":"J Endocrine Soc"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2009-1796","article-title":"Characteristics of secondary, primary, and compensated hypogonadism in aging men: evidence from the European Male Ageing Study","volume":"95","author":"Tajar","year":"2010","journal-title":"J Clin Endocrinol Metab"},{"key":"B42","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1111\/obr.12282","article-title":"Testosterone and obesity","volume":"16","author":"Kelly","year":"2015","journal-title":"Obes Rev"},{"key":"B43","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/j.lpm.2021.104080","article-title":"Prolactinomas","volume":"50","author":"Wildemberg","year":"2021","journal-title":"La Presse M\u00e9dicale"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.1007\/s11102-008-0107-5","article-title":"Hyperprolactinemia","volume":"11","author":"Chahal","year":"2008","journal-title":"Pituitary"}],"container-title":["Frontiers in Endocrinology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2023.1259529\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,11]],"date-time":"2023-10-11T07:21:33Z","timestamp":1697008893000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2023.1259529\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,10,11]]},"references-count":44,"alternative-id":["10.3389\/fendo.2023.1259529"],"URL":"https:\/\/doi.org\/10.3389\/fendo.2023.1259529","relation":{},"ISSN":["1664-2392"],"issn-type":[{"value":"1664-2392","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,10,11]]},"article-number":"1259529"}}